Boston Scientific To Participate In Citi 2017 Global Healthcare Conference

MARLBOROUGH, Mass., Nov. 27, 2017 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in the Citi 2017 Global Healthcare Conference on December 7, 2017 in New York.

Dan Brennan, executive vice president and chief financial officer *, and Susie Lisa, vice president, investor relations, will participate in a 40-minute question-and-answer session with the host analyst beginning at approximately 8:45 a.m. EST.

A live webcast of the question-and-answer session will be available on the Investor Relations section of the Boston Scientific website at  Interested parties are encouraged to register at least 15 minutes prior to the scheduled start time to ensure a timely connection.

A replay of the webcast will be accessible at beginning approximately one hour following the completion of the event.

* Revised on December 4, 2017 to reflect Dan Brennan, executive vice president and chief financial officer, as a speaker. The original press release cited Kevin Ballinger, senior vice president and president, interventional cardiology, as a speaker.  

About Boston Scientific
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world.  As a global medical technology leader for more than 35 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.  For more information, visit and connect on Twitter and Facebook.





Kate Haranis

Susie Lisa, CFA

508-683-6585 (office) 

508- 683-5565 (office)

Media Relations

Investor Relations

Boston Scientific Corporation

Boston Scientific Corporation


SOURCE Boston Scientific Corporation